glp-1 drug supply news today The of drugs tightened this week as the FDA ended compounded options. Here's what that means for folks who use the drugs for weight loss and diabetes. Click the link Many people start and stop

No large-scale clinical trials have studied microdosing specifically

Orforglipron's filing did not flag a hepatic signal, but the long-term real-world data set is just beginning

Surgery is the last resort due to the risk for complications associated with these procedures

Exclusion criteria included a history of self-reported eating disorders (eg, anorexia nervosa and bulimia nervosa), pregnancy or active attempts to conceive, known allergies or hypersensitivity to any components of the prescribed medications, and severe medical conditions such as a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, significant hepatic impairment, renal impairment requiring dialysis, uncontrolled cardiovascular diseases, or severe gastrointestinal disorders (eg, gastroparesis and pancreatitis)

What dementia prevention data actually show The most important dementia-prevention data do not point to one medication, one supplement, or one hack